The peptide was administered intravenously in varying intervals over seven days
doi: 10.1080/21641846.2022.2124775 Summary Keywords myalgic encephalomyelitis/chronic fatigue syndrome, pathology, treatment, pathophysiology, diagnostic criteria Citation Arron HE, Marsh BD, Kell DB, Khan MA, Jaeger BR and Pretorius E (2024) Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease
May help reduce the appearance of pigmentation over time 7
The side effects are rare and usually not life-threatening
[DOI] [PubMed] [Google Scholar] Thor H, Moldeus P, et al
Intranasal (IN) - The Metabolic Dampener: Prolonged IN GHK-Cu mimics canonical longevity interventions by suppressing nutrient-sensing and cellular growth networks